McKesson has announced a collaboration with Navigating Cancer to offer a patient relationship management platform for community-based oncologists.
McKesson is collaborating with Navigating Cancer to offer a technology platform they say will provide personalized care for patients and help with value-based care requirements for community-based oncologists. The patient relationship management (PRM) platform includes patient care management tools, the ability to capture patient-reported outcomes, and a nurse triage tool for symptom management.
Complementing other solutions McKesson uses that can help guide treatment options for patients, this platform will help oncologists identify which patients are responding to treatments, how they are responding, different side effects they’re experiencing, and any challenges associated with the treatment.
By taking into account these patient-reported outcomes and real-world evidence, McKesson will be able to refine the definition of precision medicine that’s appropriate for specific patients, explained Nate Gosse, senior director of project management at McKesson, in an interview with The American Journal of Managed Care®.
Through the platform, patients will have access to personalized information at all times and can report side effects before they escalate, receive medication reminders, and play a more proactive role in their care.
“The single most important place to start is with the patient experience and the quality of care that patient receives and the promptness of attention that a patient receives,” said Gosse. “Being able to efficiently, accurately, and consistently support patients as they engage with the practice, whether through a phone call or check in through the mobile web interface, that’s a critical first starting point for short-term outcomes.”
Thinking long term, Gosse said that the suite of tools will allow McKesson’s practices to have a more comprehensive understanding of what experiences and outcomes patients have on different therapies, which will enhance management capabilities.
In addition to enhancing patient experience and quality of care, the platform can also offer better utilization and cost management, as well as help providers meet value-based reporting requirements under programs such as the Oncology Care Model and Aetna’s Patient-Centered Medical Home Model, which have goals around managing not just utilization of certain drugs but also the total patient care experience and total cost of care for an individual patient.
“One of the biggest drivers for our interest in this is driven by our desire to support practices and our practices’ interest in performing total cost of care reimbursement models and total care management reimbursement models,” said Gosse. In turn, providers will be able to better manage the processes around keeping patients healthy, engaged, and out of the hospital, he said.
Dr Chakra Chaulagain: PFS Is the "Bare Minimum," but OS Is Ideal for Choosing Between MM Therapies
March 28th 2024Response rates are important when choosing between therapies to treat multiple myeloma (MM), but improvement overall survival (OS) is the ideal, said Chakra Chaulagain MD, FACP, hematologist/oncologist, Maroone Cancer Center of Cleveland Clinic Florida.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Alopecia Areata Impacts Patient Perception, Quality of Life
March 27th 2024Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Dr Chakra Chaulagain: PFS Is the "Bare Minimum," but OS Is Ideal for Choosing Between MM Therapies
March 28th 2024Response rates are important when choosing between therapies to treat multiple myeloma (MM), but improvement overall survival (OS) is the ideal, said Chakra Chaulagain MD, FACP, hematologist/oncologist, Maroone Cancer Center of Cleveland Clinic Florida.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Alopecia Areata Impacts Patient Perception, Quality of Life
March 27th 2024Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
2 Commerce Drive
Cranbury, NJ 08512